Drug Profile
AVI 6003
Alternative Names: AVI-6003; AVI-7287/AVI-7288; AVI-7288/AVI-7287Latest Information Update: 09 Aug 2012
Price :
$50
*
At a glance
- Originator AVI BioPharma; United States Army Medical Research Institute of Infectious Diseases
- Developer Sarepta Therapeutics; United States Army Medical Research Institute of Infectious Diseases
- Class Antisense elements; Antisense oligonucleotides; Antivirals
- Mechanism of Action RNA interference; Viral RNA inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Marburg virus disease